Pharmaceuticals
Advise client on legislative and administrative policy-making related to the bio-pharmaceutical industry generally, and client priorities specifically. Includes FDA and CMS related matters, as well as issues related to the development and commercialization of bio-pharmaceuticals to treat rare diseases.
HCR - Health Issues
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BGR GOVERNMENT AFFAIRS
601 13th Street, NW, 11th Floor South, Washington, DC, 20005, US
REMY LEIGH BRIM MASON (See prior filing) DAVID BOYER (See prior filing) BRENT ALAN DEL MONTE (See prior filing) ROBERT WOOD (See prior filing) ROBB WALTON (See prior filing) JOHN STONE (See prior filing) MATT HOFFMANN (See prior filing)
See prior filing See prior filing See prior filing See prior filing See prior filing See prior filing See prior filing